Clinical Studies and Trials
No overall consistent improvement in neurologic function was observed on L-Dopa.
MoreThe Platform is a patient-driven effort through which data about people with A-T are shared with researchers.
MoreGoals of this study are to develop non-invasive markers that will lessen the impact of swallowing dysfunction.
MoreThis study aimed to determine if inositol has therapeutic benefit for total lymphocyte count or ataxia.
MoreIntraBio, Inc. is studying the effects of N-Acetyl-L-Leucine on A-T.
MoreThis study seeks to develop sensitive, automated and objective means of measuring neurological disease severity.
More- « Previous
- 1
- 2